ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages
Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first lipid bilayer and the second lipid bilayer, wherein the plurality of crosslinkages comprise boronic ester or thioketal bonds. Also provided...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
10.03.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first lipid bilayer and the second lipid bilayer, wherein the plurality of crosslinkages comprise boronic ester or thioketal bonds. Also provided are pharmaceutical compositions comprising the liposomal vesicles described herein and a pharmaceutically acceptable excipient. Also provided are methods of making and using the liposomal vesicles. Thus, a method of treating a subject with a disease comprising administering to the subject a pharmaceutical composition comprising the liposomal vesicles is described herein. Methods of making multilamellar liposomal vesicles responsive to reactive oxygen species are also provided. |
---|---|
AbstractList | Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first lipid bilayer and the second lipid bilayer, wherein the plurality of crosslinkages comprise boronic ester or thioketal bonds. Also provided are pharmaceutical compositions comprising the liposomal vesicles described herein and a pharmaceutically acceptable excipient. Also provided are methods of making and using the liposomal vesicles. Thus, a method of treating a subject with a disease comprising administering to the subject a pharmaceutical composition comprising the liposomal vesicles is described herein. Methods of making multilamellar liposomal vesicles responsive to reactive oxygen species are also provided. |
Author | Morton, Stephen Wang, Zhan |
Author_xml | – fullname: Morton, Stephen – fullname: Wang, Zhan |
BookMark | eNqNzU0KwjAQQOEsdOHfHcYDFFqK0LWiuBOsui1DmbSBSSZkYsHb24UHcPU2H7y1WQQJtDKv-60tEmmUoG4i8G_OjtETMyZgF0XFI8NE6nomBSsJMqaBsgsDuGBn7DFL-oDHPkkccSDdmqVFVtr9ujH7y_lxuhYUpZtv2FOg3D3bqjw0ddnUx6r-x3wB-388wA |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US10583083B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US10583083B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:15:35 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US10583083B13 |
Notes | Application Number: US201715672589 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200310&DB=EPODOC&CC=US&NR=10583083B1 |
ParticipantIDs | epo_espacenet_US10583083B1 |
PublicationCentury | 2000 |
PublicationDate | 20200310 |
PublicationDateYYYYMMDD | 2020-03-10 |
PublicationDate_xml | – month: 03 year: 2020 text: 20200310 day: 10 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | Verily Life Sciences LLC |
RelatedCompanies_xml | – name: Verily Life Sciences LLC |
Score | 3.1763294 |
Snippet | Provided herein are liposomal vesicles comprising at least a first lipid bilayer and a second lipid bilayer, and a plurality of crosslinkages between the first... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200310&DB=EPODOC&locale=&CC=US&NR=10583083B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwjSt2C3fix7GMLalSHsg32xt5HWBCdrO9Y6_30vsXO-6FtpS0guuftdcr-7ADyGjZqq8hZShsuFIl5blLnSptI1lXseMamj572-253aL3NnXoL3XS6MrhP6qYsjokZFqO-5ttfr_SGWr7mV2VO4xFfpczBp-UaxO67rSpeG3251hgN_4Bme15qOjf4IfV2HWehutHGndFB3LFfR_zqztspKWf-GlOAUDofYWpKfQUkkFTj2djevVeCoVwS88bHQvewcZqPBmG4KSutWEE0FxPlU9KUNWS3XaZbGfEW2ItNUN4LuKPkmeiM8EVxJ-HOsg-ok5urmrje0JdkFPASdidel2MHFjzQW0_F-LNYllJM0EVdAmlHERLOB5so2bcEl56-mKxGBec1yQsmuofp3O9X_Pt7AiZIs1SS2Wyjnmw9xh0ich_dahF_CH497 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokbxqyZmb43DjTEeFpN9EFTYCAPCG9lGFzGwETbx3_dah_iib03bNO2td7_r7tcrwH3YrPMsbyHVcbtQxGuF6lqs0liTuXse6bGInvdcrTNSXyaNSQnet3dhRJ7QT5EcETUqQn3Phb1e7X5i2YJbmT2Ec6xKn9pDw5aK0_GjyHQp2abh9D3bsyTLMka-5A7Q123oCrobJp6U9lCnZE7_c8Ymv5Wy-g0p7SPY7-NoSX4MJZZUoWJtX16rwkGvCHhjsdC97ATGA8-n64LSumFEUAHxe3L60pos5qs0S5fBgmxYJqhuBN1R8k30RngiuJOw81IE1cky4C93vaEtyU7hru0MrQ7FCU5_pDEd-bu1KGdQTtKEnQNpRZHOWk00V6qssiAOgpmsxYjAQV1phLF-AbW_x6n913gLlc6w1512n93XSzjkUqaC0HYF5Xz9wa4RlfPwRojzC52DkmU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ROS-responsive+multilamellar+liposomal+vesicles+for+targeting+inflammatory+macrophages&rft.inventor=Morton%2C+Stephen&rft.inventor=Wang%2C+Zhan&rft.date=2020-03-10&rft.externalDBID=B1&rft.externalDocID=US10583083B1 |